Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non–Small-Cell Lung Cancer

Por Reck, Martin, Wehler, Thomas, Orlandi, Francisco, Nogami, Naoyuki, Barone, Carlo, Moro-Sibilot, Denis, Shtivelband, Mikhail, González Larriba, Jose Luis, Rothenstein, Jeffrey, Früh, Martin, Yu, Wei, Deng, Yu, Coleman, Shelley, Shankar, Geetha, Patel, Hina, Kelsch, Claudia, Lee, Anthony, Piault, Elisabeth, Socinski, Mark A.
Publicado no J Clin Oncol (2020)

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results F...

Por Hortobagyi, Gabriel N., Chen, David, Piccart, Martine, Rugo, Hope S., Burris, Howard A., Pritchard, Kathleen I., Campone, Mario, Noguchi, Shinzaburo, Perez, Alejandra T., Deleu, Ines, Shtivelband, Mikhail, Masuda, Norikazu, Dakhil, Shaker, Anderson, Ian, Robinson, Douglas M., He, Wei, Garg, Abhishek, McDonald, E. Robert, Bitter, Hans, Huang, Alan, Taran, Tetiana, Bachelot, Thomas, Lebrun, Fabienne, Lebwohl, David, Baselga, José
Publicado no J Clin Oncol (2016)

Randomized Phase II Study of Carboplatin and Paclitaxel With Either Linifanib or Placebo for Advanced Nonsquamous Non–Small-Cell Lung Cancer

Por Ramalingam, Suresh S., Shtivelband, Mikhail, Soo, Ross A., Barrios, Carlos H., Makhson, Anatoly, Segalla, José G.M., Pittman, Kenneth B., Kolman, Petr, Pereira, Jose R., Srkalovic, Gordan, Belani, Chandra P., Axelrod, Rita, Owonikoko, Taofeek K., Qin, Qin, Qian, Jiang, McKeegan, Evelyn M., Devanarayan, Viswanath, McKee, Mark D., Ricker, Justin L., Carlson, Dawn M., Gorbunova, Vera A.
Publicado no J Clin Oncol (2015)